Apreo raises $130M for pivotal trial of emphysema device

The company, which received investment from the venture capital wing of Intuitive Surgical, has designed the device to work in a broader patient population than existing treatments.

By Nick Paul Taylor • Aug. 11, 2025

Tandem, Insulet monitoring CMS payment proposal for diabetes tech

The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for diabetes devices, if finalized.

By Elise Reuter • Aug. 8, 2025

Explore the Trendline➔

Top 5 stories from MedTech Dive

From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.

By MedTech Dive staff

Masimo appoints several senior execs, resolves cyber incident

The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but investors have raised questions about the status of a partnership with Philips.

By Susan Kelly • Aug. 8, 2025

Boston Scientific updates instructions of devices linked to 17 deaths

The update covers devices used in procedures to implant the company’s Watchman heart device.

By Nick Paul Taylor • Aug. 8, 2025

Boston Scientific tells users about defibrillator problem linked to deaths, injuries

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the leads cannot be assumed or confirmed.

By Nick Paul Taylor • Aug. 7, 2025

Tandem insulin pump malfunction linked to 59 injuries

 A problem with speakers in Tandem’s t:slim X2 insulin pumps can cause insulin delivery to stop, the company said.

By Elise Reuter • Aug. 7, 2025

Trump plans 100% tariffs for semiconductor imports

Chips are one of several product types currently under Section 232 investigation by the White House, a frequent precursor to duties.

By Philip Neuffer • Aug. 7, 2025

BD commits $35M to expand US syringe production plant

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to above 750 million units.

By Nick Paul Taylor • Aug. 6, 2025

FTC moves to block Edwards’ JenaValve acquisition

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

By Susan Kelly • Aug. 6, 2025

Medical device industry says future MDUFA hikes unsustainable

Device lobbyists’ priorities contrasted with patient advocates, who sought an increase in user fees and more funds for postmarket safety.

By Elise Reuter • Aug. 5, 2025

EU delays countermeasures to US tariffs by 6 months

The bloc has now paused implementation three times, with the latest moratorium coming after reaching a framework deal with the U.S.

By Philip Neuffer • Aug. 5, 2025

Philips BiPAP machine recall associated with 8 deaths

Philips sent updated instructions after disclosing problems last year with an alarm that can interrupt treatment for people with obstructive sleep apnea or respiratory insufficiency.

By Elise Reuter • Aug. 5, 2025

Alcon to acquire STAAR Surgical for about $1.5B

BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.

By Susan Kelly • Aug. 5, 2025

First Corcym aortic valve implanted via new robotic procedure

CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than transcatheter aortic valve replacement.

By Susan Kelly • Aug. 5, 2025

Heartflow prices IPO, aiming to net about $180M

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 per share.

By Nick Paul Taylor • Aug. 4, 2025

Vicarious Surgical names Stephen From as next CEO

From, who joins the surgical robot developer from Aruna Bio, will take the reins from co-founder Adam Sachs on Aug. 7.

By Susan Kelly • Aug. 1, 2025

US, Mexico agree to extend USMCA-tariff pause

The two countries will continue to negotiate over a 90-day period during which imports from Mexico will avoid a planned 30% tariff from the Trump administration. 

By Philip Neuffer • Aug. 1, 2025

Monogram robot marks autonomy milestone; Stereotaxis catheter cleared

Monogram Technologies conducted its first fully autonomous robotic knee replacement surgery, while Stereotaxis won FDA clearance for a robotically navigated electrophysiology mapping catheter.

By Susan Kelly • July 31, 2025

Dexcom raises sales expectations, discusses G8 plans

Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and over-the-counter devices to drive future growth.

By Elise Reuter • July 31, 2025

Cardiosense wins FDA clearance for wearable heart monitor

The device captures various types of heart data that could be used in AI models for cardiovascular parameters with the aim of lowering barriers to monitoring.

By Nick Paul Taylor • July 31, 2025

Dexcom CEO Kevin Sayer to step down

Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.

By Elise Reuter • Updated July 31, 2025

GE HealthCare projects reduced tariff expense

Executives also said demand for capital equipment continues to be healthy. However, investors may have expected stronger order growth.

By Susan Kelly • July 30, 2025

Siemens Healthineers cuts tariff impact after trade talk breakthrough

The company predicted a full-year impact of 200 million to 250 million euros, down from its previous forecast of up to 300 million euros.

By Nick Paul Taylor • July 30, 2025

Philips lowers expected tariff hit to 150M to 200M euros

The company previously forecast an up to 300 million euro tariff impact in 2025 before the U.S. struck agreements with China and the European Union.

By Elise Reuter • July 29, 2025

J&J’s Ethicon recalls stapler cartridges over issue linked to 1 death

The FDA said the device can lock, leading to adverse events including surgical delay, bleeding and death.

By Nick Paul Taylor • Updated July 29, 2025